![]() |
市場調查報告書
商品編碼
1383332
2030 年工業生物技術市場預測:按類型、原料、應用和地區分類的全球分析Industrial Biotechnology Market Forecasts to 2030 - Global Analysis By Type (Biochemical, Biofuel, Bioproduct and Other Types), Raw Material, Application and By Geography |
根據 Stratistics MRC 的數據,全球工業生物技術市場在預測期內預計將以 11.9% 的年複合成長率成長。
“工業生物技術市場”一詞,也稱為“白色生物技術”,描述了利用生物技術概念、設備和流程在工業規模上創造和生產產品。它利用細菌、酵母和酵素等活生物體來生產比傳統化學製程更彈性、更環保、更實用的生物基產品、方法和解決方案。該市場包括農業、生物燃料、化學品、製藥、食品和食品和飲料製造、環境管理和其他行業。生物技術領域未來的發展將對維護人類生命健康、提高生活品質、促進區域經濟發展產生重大影響。
根據世界衛生組織(WHO)2022年2月發布的資料,癌症是全球頭號死亡原因,2020年約佔1,000萬人死亡,佔總死亡人數約6人。
基因工程、合成生物學和精確基因組編輯等生物技術方法和工具的發展進步已經改變了工業生物技術的能力。借助這些發展,微生物和酵素可以改進和最佳化,以生產各種生物基產品,如生物燃料、特殊化學品、生物製藥和生物基材料。此外,透過提高生物系統的精確度和控制,生物技術人員可以創造具有改善的代謝途徑的微生物。
開發生物技術製程、實驗室和基礎設施需要大量資金,這可能成為新業務企業和現有企業的障礙。生物技術產業經常需要最尖端科技、昂貴的專業設備和訓練有素的工人。然而,開發和改進生物技術製程在研究和開發階段可能需要大量的時間和資源。由於初始成本高昂,生物技術產品的商業化可能會被推遲,導致財務資源緊張。
近年來,消費者對環保、永續生產和道德生產產品的偏好發生了顯著變化。這種思維轉變正在推動對使用生物技術方法生產的產品的需求,這些產品本質上是永續的。此外,工業生物技術能夠生產永續的生物基產品、生物燃料和特殊化學品,這些產品對環境的危害比傳統產品小。消費者擴大尋求能夠反映他們的價值觀並解決對氣候變遷和商品枯竭的擔憂的替代品。
生物技術產業在一個複雜的法律規範內運作,其特點是不斷變化的法規和嚴格的審查,因為生物技術工藝和產品可能對環境和人類健康產生負面影響。Masu。對於新的生物技術產品和工藝,獲得法規的核准是一個耗時且成本高昂的過程,並且受到嚴格的安全法規的約束。然而,由於法規不確定性,公司可能不願意在生物技術領域進行創新,這可能導致商業化和市場准入的延遲。
供應鏈中斷和某些計劃被推遲的事實是一個副作用,但進一步證明了生物技術在解決世界問題方面的重要性。對生物技術產品的需求正在增加,特別是在疫苗的生產和醫療保健行業。工業生物技術在 COVID-19 疫苗的快速生產中發揮了關鍵作用,展示了該行業的彈性和創新能力。然而,與疫情和當前經濟狀況有關的法規暫時損害了投資,並減緩了其他經濟領域的一些生物技術業務的發展。
由於使用生物過程和生物體製造各種化學品的廣泛應用,生化領域在預測期內佔據了市場的最大佔有率。該部門對於推廣環保和永續的製造方法至關重要。此外,化學品、特殊化合物和生物基材料(例如生物分解性塑膠)的生產需要使用微生物、酵素和其他生物催化劑來取代傳統的化學合成過程。生物化學領域的應用遍及各個領域,包括製藥、農業、食品和飲料和飲料以及化妝品。
食品廢棄物領域預計將呈現良好的成長。在工業生物技術產業中,食品廢棄物部分解決了最大限度減少食品廢棄物和利用有機廢棄物生產付加產品的重要問題。工業生物技術利用微生物和酵素過程來分解複雜的有機化合物,回收寶貴的資源,並減少食物廢棄物處理對環境的影響。此外,透過從原本會被浪費的廢物中創造出有價值的產品,這些綠色和永續的方法不僅可以減少食品廢棄物造成的環境問題,而且可以支持循環經濟,也將為您提供支持。
由於經濟強勁發展、人口膨脹和環保意識不斷增強,亞太地區佔了最大佔有率。該地區對生物基材料產品的需求不斷增加,特別是在農業、能源和醫療保健等關鍵產業。此外,政府對生物基公司和綠色技術的計畫和法規支持也正在加速該地區工業生物技術的發展。在中國和印度等國家尤其如此,它們廣泛利用研究和開發來提高其生物技術能力。
由於其對永續性的堅定承諾、嚴格的環境標準和完善的行業形勢,歐洲預計將在預測期內實現盈利成長。隨著該地區致力於最大限度地減少環境影響並轉向環保的生物基解決方案,工業生物技術已成為關鍵的創新驅動力。Masu。此外,歐洲法規對生物技術創新的大力支持,特別是在製藥、化學品和農業等領域,正在推動顯著成長。
According to Stratistics MRC, the Global Industrial Biotechnology Market is expected to grow at a CAGR of 11.9% during the forecast period. The term "industrial biotechnology market," also referred to as "white biotechnology," describes the use of biotechnological concepts, instruments, and processes to create and produce products on an industrial scale. It involves utilizing living organisms, such as bacteria, yeast, and enzymes, to produce bio-based products, methods, and solutions that are more flexible, eco-friendly, and practical than conventional chemical-based processes. Agriculture, biofuels, chemicals, medicines, food and beverage production, environmental management, and other industries are included in the market. The preservation of human life and health, the enhancement of life quality, and the promotion of regional economic development will all be significantly impacted by the development of the biotechnology sector in the future.
According to the data published by the World Health Organization, in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.
The capabilities of industrial biotechnology have been transformed by the ongoing development of biotechnological methods and tools, such as genetic engineering, synthetic biology, and precise genome editing. With the help of these developments, microbes and enzymes can be modified and optimized to produce a variety of bio-based products, such as biofuels, specialty chemicals, biopharmaceuticals, and biobased materials. Additionally, biotechnologists can create microorganisms with improved metabolic pathways due to their increased precision and control over biological systems, which will increase yields and enable more efficient production.
Substantial capital is needed to develop biotechnological processes, laboratories, and infrastructure, which can be a barrier for both new and current businesses. Cutting-edge technologies, expensive specialized gear, and highly trained workers are frequently needed in the biotechnology industry. However, developing and refining biotechnological processes may require an enormous amount of time and resources during the research and development stage. The commercialization of biotech products may be delayed by these high initial expenditures, which may pose a burden on financial resources.
Consumer preferences for products that are environmentally friendly, sustainably made, and manufactured ethically have changed substantially in recent years. Due to this shift in perspective, there is a growing demand for products produced by biotechnological methods, which are by nature more environmentally friendly and sustainable. Furthermore, industrial biotechnology makes it possible to create sustainable bio-based products, biofuels, and specialty chemicals that are less harmful to the environment than their conventional counterparts. Consumers are increasingly seeking alternatives that reflect their values and address their worries about climate change and the depletion of commodities.
Due to the possible negative effects of biotechnological processes and products on the environment and human health, the biotech industry operates in a complex regulatory framework characterized by changing regulations and intense scrutiny. For novel biotech products or processes, obtaining regulatory approvals can be a time-consuming and expensive procedure with stringent safety regulations. However, companies may be reluctant to engage in biotechnological innovations because of regulatory uncertainty, which can cause delays in commercialization and accessibility to markets.
The fact that supply chains experienced disruption and certain projects were delayed is a side effect, but it further demonstrates the importance of biotechnology in tackling global problems. The need for biotechnology products has increased, particularly in the creation of vaccines and the healthcare industry. A crucial role in the rapid creation of COVID-19 vaccines was played by industrial biotechnology, demonstrating the sector's flexibility and capacity for innovation. Restrictions associated with the epidemic and the current condition of the economy, however, have temporarily harmed investments and slowed down the development of several biotech businesses in other sectors of the economy.
Due to the wide range of applications that use biological processes and organisms to manufacture various chemicals, the biochemical segment held the largest share of the market over the forecast period. This sector is essential for promoting environmentally friendly and sustainable manufacturing methods. Moreover, in order to produce chemicals, specialty compounds, and bio-based materials like biodegradable plastics, it entails replacing traditional chemical synthesis processes with the use of microbes, enzymes, and other biocatalysts. Applications of the biochemical sector can be found in a variety of fields, including pharmaceuticals, agriculture, food and beverage, and cosmetics.
Food Waste segment is anticipated to witness lucrative growth. Within the industrial biotechnology industry, the food waste segment addresses the crucial problem of minimizing food waste and utilizing organic waste materials to produce products with added value. Industrial biotechnology uses microbes and enzymatic processes to break down complex organic compounds, recover valuable resources, and reduce the environmental impact of disposing of food waste. Moreover, by creating valuable products from garbage that would otherwise go to waste, these environmentally friendly and sustainable methods not only reduce the environmental problems caused by food waste but also support the circular economy.
Due to its robust economic development, expanding population, and rising awareness of the environment, the Asia-Pacific area accounted for the largest share. Particularly in important industries such as agriculture, energy, and healthcare, the region has experienced an increase in demand for products made from bio-based materials. Furthermore, government programs and regulatory assistance for bio-based companies and green technologies have also accelerated the development of industrial biotechnology in the area. This is especially apparent in nations like China and India, which have extensively used R&D to improve their biotechnology abilities.
Due to its strong dedication to sustainability, strict environmental standards, and well-established industrial landscape, Europe is predicted to experience profitable growth during the projected period of time. The region's emphasis on minimizing its environmental impact and transitioning to eco-friendly, bio-based solutions has elevated industrial biotechnology to the position of a major innovation driver. Moreover, significant growth has been facilitated by Europe's solid regulatory support for biotechnological innovations, particularly in areas like pharmaceuticals, chemicals, and agriculture.
Some of the key players in Industrial Biotechnology market include: BASF SE, Codexis, Inc., Fermentalg, Borregaard AS, Gevo, Inc., Global Bioenergies, Evolva, Amyris, Inc., Novozymes and Deinove.
In October 2023, BASF invests a high double-digit million euro amount in a new fermentation plant for biological and biotechnology-based crop protection products at its Ludwigshafen site. The plant will manufacture products that bring value to farmers including biological fungicides and biological seed treatment. BASF also plans to utilize the plant to produce the main building block of Inscalis®, a novel insecticide derived from a fungal strain.
In June 2023, The German chemicals giant has announced it would increase its global alkyl polyglucosides (APGs) production capacity with two expansions at its sites in Bangpakong, Thailand, and Cincinnati, Ohio.